Konidaris Tasos

CIK 00013209825 companiesSHORT HILLS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001320982

Recent Transactions

50 trades

Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-15$9.43/sh−219,159→ 122,152 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-14$9.30/sh−119,206→ 341,311 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-13$9.22/sh−161,365→ 460,517 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-05$8.91/sh−100,000→ 621,882 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+43,981→ 744,379 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04−43,981→ 131,945 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−22,497→ 721,882 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+228,310→ 228,310 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−92,663→ 700,398 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−181,159→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−16,373→ 578,936 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+45,290→ 595,309 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−57,340→ 114,679 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+114,155→ 114,154 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−24,374→ 611,902 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+57,340→ 636,276 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+181,159→ 793,061 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−45,290→ 45,290 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-01−36,197→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01$8.67/sh−13,494→ 550,019 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01+36,197→ 563,513 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-12$5.31/sh−30,790→ 527,316 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-12−87,720→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-12+87,720→ 558,106 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+351,852→ 351,852 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+175,926→ 175,926 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−45,290→ 90,580 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−20,126→ 470,386 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−57,339→ 172,019 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+45,290→ 449,070 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−15,897→ 433,173 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+57,339→ 490,512 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-01−36,197→ 36,197 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01+36,197→ 417,037 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01$5.47/sh−13,257→ 403,780 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-12−87,719→ 87,720 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-12+87,719→ 380,840 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2023-03-03+458,716→ 458,716 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03+229,358→ 229,358 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-03−45,289→ 135,870 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-03+45,289→ 293,121 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2023-03-01−36,197→ 72,394 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-03-01+36,197→ 247,832 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-03-12−87,719→ 175,439 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2022-03-12+87,719→ 211,635 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-03-03+181,159→ 181,159 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2022-03-03+362,318→ 362,318 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2022-03-01+36,197→ 123,916 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2022-03-01−36,197→ 108,591 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-11-09$6.15/sh−50,000→ 0 total

Companies

Recent Filings

Address

103 JFK PARKWAY

SHORT HILLS, NJ, 07078

View on SEC.gov